Publications by authors named "Dmitry Khochenkov"

Claim this Profile
A
Aqueous Dispersion of Unmodified Fullerene C60: Stimulation of Hair Growth and Study of a New Molecular Target for Interaction.
Nadezda Shershakova, Elena Baraboshkina, Dmitry Khochenkov, Evgeny Turetskiy, Alexandra Nikonova

Int J Mol Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of Platelet-Derived Growth Factor Alpha and Beta Receptors in Primary Tumor Cells of Patients with Renal Cell Carcinoma.
Maria Volkova, Dmitry Khochenkov, Anna Olshanskaya, Yulia Khochenkova, Elyso Solomko

Urol Res Pract· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologics-based technologies for highly efficient and targeted RNA delivery.
Anastasiya Kostyusheva, Sergey Brezgin, Natalia Ponomareva, Anastasiia Frolova, Alexander Lunin, Dmitry Khochenkov, Yulia Khochenkova

Mol Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of molecular mechanisms of riboflavin anti-COVID-19 action reveals anti-inflammatory efficacy rather than antiviral activity.
Roman A Akasov, Olga E Chepikova, Tatiana N Pallaeva, Neonila V Gorokhovets, Andrei E Siniavin, Dmitry A Khochenkov

Biochim Biophys Acta Gen Subj· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metal-(Acyclic Diaminocarbene) Complexes Demonstrate Nanomolar Antiproliferative Activity against Triple-Negative Breast Cancer.
Svetlana A Katkova, Alexander S Bunev, Rovshan E Gasanov, Dmitry A Khochenkov, Andrey V Kulsha

Chemistry· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metal-(Acyclic Diaminocarbene) Complexes Demonstrate Nanomolar Antiproliferative Activity against Triple-Negative Breast Cancer.
Svetlana A Katkova, Alexander S Bunev, Rovshan E Gasanov, Dmitry A Khochenkov, Andrey V Kulsha

Chemistry· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrochemical Nanopipette Sensor for In Vitro/In Vivo Detection of Cu Ions.
Roman V Timoshenko, Petr V Gorelkin, Alexander N Vaneev, Olga O Krasnovskaya, Roman A Akasov, Dmitry A Khochenkov

Anal Chem· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective and Reversible 1,3-Dipolar Cycloaddition of 2-(2-Oxoindoline-3-ylidene)acetates with Nitrones in the Synthesis of Functionalized Spiroisoxazolidines.
Dmitriy D Karcev, Mariia M Efremova, Alexander P Molchanov, Nikolai V Rostovskii, Mariya A Kryukova, Dmitry A Khochenkov

Int J Mol Sci· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapamycin synergizes the cytotoxic effects of MEK inhibitor binimetinib and overcomes acquired resistance to therapy in melanoma cell lines in vitro.
Oxana O Ryabaya, Ivan S Abramov, Dmitry A Khochenkov, Roman Akasov, Nataly V Sholina

Invest New Drugs· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanocurcumin-Loaded UCNPs for Cancer Theranostics: Physicochemical Properties, In Vitro Toxicity, and In Vivo Imaging Studies.
Anbharasi Lakshmanan, Roman A Akasov, Natalya V Sholina, Polina A Demina, Alla N Generalova, Dmitry A Khochenkov

Nanomaterials (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunochemical expression of fibroblast growth factor and its receptors in primary tumor cells of renal cell carcinoma.
Maria Volkova, Ilya Tsimafeyeu, Anna Olshanskaya, Yulia Khochenkova, Eliso Solomko, Dmitry Khochenkov

Am J Clin Exp Urol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of growth factors and their receptors in the primary renal cell carcinoma: new data and review.
Maria Volkova, Ilya Tsimafeyeu, Anna Olshanskaya, Yulia Khochenkova, Elyso Solomko, Dmitry Khochenkov

Cent European J Urol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A versatile platform for bioimaging based on colominic acid-decorated upconversion nanoparticles.
Polina A Demina, Natalya V Sholina, Roman A Akasov, Dmitry A Khochenkov, Natalia A Arkharova

Biomater Sci· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local Overheating of Biotissue Labeled With Upconversion Nanoparticles Under Yb Resonance Excitation.
Ivan V Krylov, Roman A Akasov, Vasilina V Rocheva, Natalya V Sholina, Dmitry A Khochenkov

Front Chem· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of Receptor Tyrosine Kinases on Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes in Patients with Renal Cell Carcinoma and Healthy Donors.
Ilya Tsimafeyeu, Maria Volkova, Anna Olshanskaia, Grigory Raskin, Saida Aschuba, Yulia Khochenkova, Dmitry Khochenkov

Oncology· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Susceptibility of Human Melanoma Cells to Infection with the Leningrad-16 Vaccine Strain of Measles Virus.
Yulia Ammour, Oxana Ryabaya, Yulia Shchetinina, Elena Prokofeva, Marina Gavrilova, Dmitry Khochenkov

Viruses· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin increases antitumor activity of MEK inhibitor binimetinib in 2D and 3D models of human metastatic melanoma cells.
Oxana Ryabaya, Anastasia Prokofieva, Roman Akasov, Dmitry Khochenkov, Marina Emelyanova

Biomed Pharmacother· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of endoplasmic reticulum stress-induced autophagy sensitizes melanoma cells to temozolomide treatment.
Oxana Ryabaya, Anastasia Prokofieva, Dmitry Khochenkov, Ivan Abramov, Alexander Zasedatelev

Oncol Rep· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autophagy inhibitors chloroquine and LY294002 enhance temozolomide cytotoxicity on cutaneous melanoma cell lines in vitro.
Oxana O Ryabaya, Andrey N Inshakov, Angelina V Egorova, Marina A Emelyanova, Tatiana V Nasedkina, Dmitry A Khochenkov

Anticancer Drugs· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models' [Eur J Cancer 61 (2016) 20-28].
Ilya Tsimafeyeu, John Ludes-Meyers, Evgenia Stepanova, Frits Daeyaert, Dmitry Khochenkov

Eur J Cancer· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models.
Ilya Tsimafeyeu, John Ludes-Meyers, Evgenia Stepanova, Frits Daeyaert, Dmitry Khochenkov

Eur J Cancer· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting liposomes loaded with melphalan prodrug to tumour vasculature via the Sialyl Lewis X selectin ligand.
Natalia R Kuznetsova, Eugenia V Stepanova, Nina M Peretolchina, Dmitry A Khochenkov, Ivan A Boldyrev

J Drug Target· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis